EP2280778A2 - Titer plate, reading device therefor and method for detecting an analyte, and use thereof - Google Patents
Titer plate, reading device therefor and method for detecting an analyte, and use thereofInfo
- Publication number
- EP2280778A2 EP2280778A2 EP09753828A EP09753828A EP2280778A2 EP 2280778 A2 EP2280778 A2 EP 2280778A2 EP 09753828 A EP09753828 A EP 09753828A EP 09753828 A EP09753828 A EP 09753828A EP 2280778 A2 EP2280778 A2 EP 2280778A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- biochip
- titer plate
- recess
- pipette tip
- recesses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 38
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000000018 DNA microarray Methods 0.000 claims abstract description 157
- 239000007788 liquid Substances 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 238000001514 detection method Methods 0.000 claims description 16
- 230000003321 amplification Effects 0.000 claims description 12
- 238000009396 hybridization Methods 0.000 claims description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 12
- 239000011541 reaction mixture Substances 0.000 claims description 12
- 238000012546 transfer Methods 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 2
- 101150107341 RERE gene Proteins 0.000 claims 1
- 238000010195 expression analysis Methods 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- 238000011109 contamination Methods 0.000 abstract description 10
- 230000010354 integration Effects 0.000 abstract description 3
- 239000000523 sample Substances 0.000 description 32
- 239000000463 material Substances 0.000 description 9
- 238000011049 filling Methods 0.000 description 8
- 239000004033 plastic Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000183024 Populus tremula Species 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000013536 elastomeric material Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000711557 Hepacivirus Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000007885 magnetic separation Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QHGVXILFMXYDRS-UHFFFAOYSA-N pyraclofos Chemical compound C1=C(OP(=O)(OCC)SCCC)C=NN1C1=CC=C(Cl)C=C1 QHGVXILFMXYDRS-UHFFFAOYSA-N 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 239000012815 thermoplastic material Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5025—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures for parallel transport of multiple samples
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/02—Adapting objects or devices to another
- B01L2200/025—Align devices or objects to ensure defined positions relative to each other
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0689—Sealing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0636—Integrated biosensor, microarrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0645—Electrodes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/069—Absorbents; Gels to retain a fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0829—Multi-well plates; Microtitration plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
Definitions
- Titer plate reading device therefor and method for the detection of an analyte, and their use
- the present invention relates to a titer plate for detecting an analyte and a reading device therefor. Furthermore, the invention relates to a method for detecting an analyte. Furthermore, the present invention involves the use of such methods, titer plates and a combination titer plate reader.
- An almost indispensable method of molecular diagnostics is an amplification of a so-called target - the analyte - by a thermocycling reaction, such as, e.g. a so-called polymerase chain reaction - short PCR.
- a thermocycling reaction such as, e.g. a so-called polymerase chain reaction - short PCR.
- the smallest, not directly detectable amounts of analyte molecules are multiplied exponentially to detectable levels.
- Manipulating samples to be amplified or amplified is extremely critical. Smallest contaminations, for example play on an aerosol, with possibly even only single molecules would lead to sample material with false positive or increased quantitative results. Therefore, it is common in molecular diagnostics to perform sample preparation and amplification in separate rooms. However, this is very expensive and requires the processing of the samples by laboratory staff.
- a product of the hybridization reaction with the amplified analyte can be detected electrically.
- the exemplary named quicklab® is disclosed, for example, in DE 102 33 212 A1.
- Another arrangement for a biochip is known from DE 100 58 397 A1.
- DE 101 26 341 A1 teaches a biochip which changes an electrically detectable property by hybridization with an analyte. It is an object of the present invention to provide a titer plate which allows for improved automated handling of the amplified samples.
- the invention particularly comprises a first embodiment of a titer plate according to claim 1.
- the well plate according to the invention preferably has recesses which are arranged at intervals corresponding to the Abstän ⁇ at a standard microtiter plate, so that the titer plate of the invention can be operated by a pipetting robot.
- This standard distance is eg 9mm.
- the titer plate preferably has the length and width of a standard titer plate, eg, it preferably conforms to the standard 12x8 well titer plate format.
- the thickness of the titre plate according to the invention is preferably larger in order to accommodate the wall, each of which surrounds a biochip and a plurality of recesses, as wei ⁇ ter be described in more detail below.
- Biochip is understood to mean a chip which is suitable for the detection of an analyte, for example a specific DNA, and is particularly suitable for application of an analyte. senity of the analyte generates an electrical signal.
- the biochip to one or more sensitive FLAE ⁇ chen with capture molecules, each specifically binding to an analyte.
- Several sensitive surfaces with different capture molecules can be arranged on a biochip, eg 8 to 400, particularly preferably 64 or 128 sensitive surfaces or "spots.”
- the biochip is, for example, a CMOS chip with universal zip-code catchers.
- a plurality of biochips, in particular 6 to 24, preferably 12 biochips are present on a titer plate, so that, for example, 12 random access multiplex assays can be performed.
- the analyte molecules bind to the capture molecules, for example, hybridize with them, for example, is effected a change in the capacitance of the sensitive surface, the electrically who can read ⁇ .
- the analyte or the target is biotinylated.
- a label enzyme such as streptavidin or AG phosphatase is added. This enzyme binds to the biotin of the target.
- a substrate is subsequently added, a reaction product is produced which generates an electrical signal that can be read by the biochip.
- the biochip is designed for the detection of DNA by means of hybridization to suitable capture molecules.
- the sensitive surface (s) of the biochip on one side are ordered at ⁇ while the contacts, where the electrical Sig- can be read nal, on a duly opposite ⁇ the side of the biochip disposed are.
- 5 to 100 advertising tested in particular 8 to 12 sensitive areas and entspre ⁇ accordingly arranged many contacts to a biochip so that simultaneously a plurality of different analytes the can.
- the biochip is preferably embedded in the titer plate, for example, the biochip is embedded in a plastic ring, which in turn is inserted into a suitable recess of the titer plate, so that sample or reaction material can be brought into contact with the preferably upwardly facing sensitive surfaces of the biochip ,
- the biochip on the side of the sensitive surfaces - for example, upwards - provided with a seal which prevents impurities can penetrate the catcher molecules.
- the seal is for example a cover of an elastomeric and / or thermoplastic material.
- the biochip preferably extends over a region on which, in the case of a standard titer plate, a fixed number, such as e.g. 2, 4, 6 or 8 wells are arranged.
- a pipetting robot can stop and aspirate or dispense material. This allows the biochip of pipetting robots to be filled with sample material, reaction material or with label enzymes and substrate.
- a plurality of depressions or holes are respectively arranged in which, for example, an amplification of the target can be carried out, for example by means of a PCR reaction, or other reagents can be provided.
- an amplification of the target can be carried out, for example by means of a PCR reaction, or other reagents can be provided.
- one biochip and several of the wells each form a unit within which a particular analysis is performed. This unit is surrounded by a wall. In a ⁇ standardize all necessary steps for the detection can be carried leads.
- the spatial separation of the units allows many units to be accommodated in a very small area without risking contamination of the individual samples. A massively parallel examination of very many samples is possible quickly and inexpensively.
- a unit surrounded by a wall includes 2, 4, 6, 8, or 10 wells and one, two, or three biochips.
- 4 wells and 1 biochip form one Unit, where the biochip occupies an area that is also taken up by 4 wells in a standard titer plate.
- a preferred unit thus corresponds to 8 wells and thus has 8 positions in which a pipetting robot can handle a pipette tip.
- a titer plate in standard 12x8 format thus has 12 units which are each separated by a wall from each ⁇ .
- the titer plate according to the invention is, for example, a block of about 20-70 mm, preferably of 45 ⁇ 10 mm height, wherein the wall between the individual units is formed by each unit being arranged in a kind of recess in the block.
- the depressions and the biochip are arranged at the bottom of the recess.
- the pipetting robot may be a pipette tip from one well to the next well or to the biochip various ⁇ ben within the recess.
- the wall surrounding the biochip and a plurality of depressions is the wall of the recess and is preferably about as high as the height of the titer plate, ie preferably about 20-70 mm, preferably 45 ⁇ 10 mm high. This effectively prevents can get from a one ⁇ ness in an adjacent unit during pipetting individual droplets.
- the titer plate preferably has as many recesses as units from a plurality of wells and a biochip.
- Such a recess is preferably only open to a first side, in particular the upper side of the titer plate.
- a pipette can be introduced through the recess and remains during the transfer of
- the first side opposite ⁇ opposite side, preferably the bottom, of the titer plate provides a housing for the biochip prepared and provided with training bulges which in each case one recess entspre ⁇ chen.
- the recesses are formed respectively in the form ei ⁇ nes elongated hole and have for each unit, for example, in about a "E" shape.
- the Ausneh ⁇ rules are fit reasonable course of movement of a pipetting robot.
- the oblong hole extends over all four recesses and at least one position above the biochip, which forms a single connecting line between the recesses and the biochip, which has the advantage that walls are arranged not only between the individual units, but also in part between the individual recesses within a unit
- the titer plate is preferably made of plastic. Since it is preferably equipped with recesses which are open to one side, it is possible to produce the titer plate (without biochips) by injection molding. Preferably, the walls or recesses and the recesses are made as a one-piece plastic injection-molded part, in which later the biochips are embedded. Alternatively, the titer plate can also be formed as a flat plate with recesses and receptacles for the biochips, are placed on the wall elements between the individual units. Since in this case, a seal between wall elements and plate must be taken care of, this embodiment is not preferred.
- the biochip is preferably such in the titer plateLet ⁇ tet that each corner of the biochip is located at the corresponding Posi tion ⁇ a recess on the microtiter plate in a standard format. At least one of these positions is a Einyogllport in an elastomeric cover or seal the biochip present.
- the elastomeric seal serves to protect the sensitive surfaces of the biochip from contamination. You can, for example, moved into a two-component injection molding used in the preparation of the titer plate in this integ ⁇ riert.
- the seal or cover is clamped by a plastic ring, in which the biochip is embedded.
- the elastomeric seal is slightly spaced from the sensitive surface of the biochip, whereby a biochip chamber is formed therebetween, which is in fluid communication with the sensitive surfaces of the biochip.
- liquid can preferably be injected into the biochip chamber, which then comes into contact with the catcher molecules and is thus analyzed by the biochip. Since the filling port of the biochip is, as it were, "aligned" with one of the standard positions of the wells of a titer plate, a pipette can automatically transfer a sample to the biochip by means of the pipetting robot.
- At least one and preferably two storage positions for a pipette tip are provided above the elastomeric seal of the biochip, namely at one or preferably two of the eg 4 positions, each corresponding to a depression on a standard titer plate and so ⁇ with by a Pipetting robot can be reached.
- a pipette that has come into contact with the sample material can be deposited at this point and thus remain within the unit, even if fresh pipette tips are possibly present in the unit
- an overflow reservoir is preferably provided for each unit to receive excess fluid.
- the overflow reservoir is connected directly to the biochip chamber or can be connected. Consequently If liquid that is filled into the biochip chamber runs directly into the overflow reservoir. Since the biochip is preferably embedded in the bottom of the titer plate, the overflow reservoir is preferably located above the biochip chamber. Therefore, the overflow reservoir is preferably provided with a wick or other absorbent material which draws the liquid from the chip chamber. In this way, all the fluid that is pressed through the chip chamber is received by the overflow reservoir.
- the overflow reservoir preferably holds 0.5 ml to 5 ml, more preferably 1-2 ml.
- the overflow reservoir is preferably provided with egg ⁇ ner overflow wall that prevents back flow of liquid in the biochip chamber.
- the overflow reservoir also be filled, for example through an inlet at one of the standard positions Alternatively, corresponding to the wells of a titer plate stardard.
- the invention comprises a titer plate for the detection of an analyte, with at least one biochip, wherein the at least one biochip for
- Detection of an analyte is designed and is from a wall ⁇ give, with a seal, preferably an elastomeric seal on which at least one biochip (14) is applied, which defines a biochip chamber together with the biochip and with an overflow reservoir directly with the biochip chamber is connected or connectable.
- a seal preferably an elastomeric seal on which at least one biochip (14) is applied, which defines a biochip chamber together with the biochip and with an overflow reservoir directly with the biochip chamber is connected or connectable.
- the overflow reservoir is preferably located above the biochip chamber. Therefore, the overflow reservoir is preferably provided with a wick or other absorbent material which draws the liquid from the chip chamber. In this way, all the fluid that is pressed through the chip chamber is received by the overflow reservoir.
- the titer plate according to the invention may be penetrated by at least one bore.
- This bore extends transversely to the carrier material of the titer plate and preferably opens between the depressions and the biochip.
- a negative pressure can be applied by means of this, in order to suck off possible droplet impurities from the space above the titer plate.
- each unit or recess is equipped with its own bore.
- the invention is indicated on a reading device for a titer plate which is adapted to ensure a white ⁇ tere improve the automatic handling of samples.
- the reading device provides at least one electrical contact or read-out area for the biochip.
- the read-out surface can be heated, since the readout result of the biochip can usually only be read out after suitable heat treatment.
- the reading device also includes trays for the recesses, preferably as heated seats (thermoblocks) konzi ⁇ are piert.
- thermoblocks heated seats
- a recess in a pan is taken in each case, preferably the recess is concluded as closely as possible environmentally from the pan to ensure a good heat transfer.
- the recess is concluded as closely as possible environmentally from the pan to ensure a good heat transfer.
- an independent thermo-cycle unit hereinafter also called thermoblock.
- a reading device has mutually independent units each having four trays and a contact surface. It is a further object of the present invention to provide an improved method for detecting an analyte by means of a biochip.
- a titer plate according to the invention By using a titer plate according to the invention, a so-called “liquid handling” can take place by means of a pipetting robot.
- the method preferably comprises an amplification of the analyte and offers the advantage of a spatial integration of a hybridization region of the biochip in a common space. Contamination of other sample materials is effectively avoided because the pipette tip remains in the ⁇ sem space.
- a plurality of pipette tips may be used by the pipetting robot for each unit, which remain within each unit after use. This has the advantage that adjacent units can not be contaminated with amplified material as the pipette tip is transported away across them. Used pipette tips are particularly preferably stored on the storage positions on an ex ⁇ cover or seal of the biochip.
- the reaction mixtures from the different wells with different pipette tips can successively be transferred into the biochip chamber and the biochip read out.
- the pipette tip is thereby completely emptied over the biochip chamber, wherein excess liquid flows into the overflow reservoir.
- the pipette tip is preferably deposited on the same well from which the PCR reaction mixture was transferred.
- a fresh pipette tip is used, which in turn remains in the unit or recess.
- another liquid in particular a label liquid
- a pipette tip onto the biochip or into the biochip chamber.
- the label is, for example, streptavidin or AG phosphatase, which binds to the biotinylated analyte.
- the pipette tip used to transfer the label has not yet been emptied, as it may be reused for further samples, and is therefore parked in one of the storage or parking locations.
- a substrate is preferably pipetted into the biochip chamber with another pipette tip.
- This forms a reaction product which triggers an electrical signal on the biochip.
- the pipette tip, with which the substrate was transferred has not yet been emptied, as it is used for any additional samples again, and since ⁇ her parked on a second filing or park positions.
- the preferred method is that multiple pipette tips, e.g. remain on different storage positions or in the recesses within the recess.
- thermocyclization reaction For amplification of the analyte, a thermocyclization reaction is preferably used. According to a further development of the method according to the invention, a polymerase chain reaction - in short PCR -, an allele-specific primer expression - ASPE for short - and / or a so-called Amplification Refractory Mutation System - ARMS for short.
- a temperature-controlled hybridization by means of the biochip is also provided here.
- An improved detection of the analyte is also achieved by a temperature-controlled electrical, in particular electrochemical, detection. Furthermore, to improve the automatic handling of samples, an analysis device of a combination of Leseein ⁇ direction and titer plate is specified. This combination is adapted to standard pipetting robots.
- Another aspect of the present invention relates to the use of the titer plate according to the invention.
- the wells of one unit can be used with four different reference concentrations for quantitative determinations. This is conceivable for expression experiments in the integrated DNA technique or multiple multiplexing in so-called single nucleotide polymorphism (SNP for short).
- SNP single nucleotide polymorphism
- Fig. 1 is a perspective view of an embodiment of a titer plate according to the invention.
- FIG. 2 shows a perspective view of an embodiment of a reading device for a titer plate according to the invention
- FIG. 3 is a perspective view of a combination of a titer plate according to Figure 1 with a Leseein ⁇ direction in FIG. 3;
- FIG. 4 is a plan view of a section of the Obersei ⁇ te the titer plate according to the invention.
- FIG. 5 shows a longitudinal section through a section of a titer plate and a reading device according to a second embodiment
- FIG. 6 shows a flowchart of a method according to the invention rens.
- FIG. 1 shows a titer plate 10 for detecting an analytical th 22 from the bottom of the titer plate 10 includes a plurality of recesses arranged in rows 12 which are visible as bulges 12 'from the lower side ⁇ 22nd
- the recesses 12 are spaced from each other such and being rich ⁇ tet that a pipetting robot with a pipette tip can contribute to the analyte sample to be tested into the recesses 12 required reagents, solvents, and / or a.
- biochips 14 In addition to two rows of wells 12 a number of biochips 14 is arranged.
- the biochip 14 are also positioned in Be ⁇ train to the recesses 12 such that the Ro ⁇ boter the pipette tip can get moved automatically program-ert.
- These biochips 14 are designed, for example, to detect a DNA by means of hybridization, wherein at least one electrical property of the biochip 14 changes.
- Such biochips 14 may possibly also include a chip card laboratory.
- the titer plate 10 is modular, it comprises a block, for example an injection molded part, made of plastic, in which the depressions 12 or bulges 12 'are formed, and the biochips 14. These are accommodated in receptacles 14' in the block.
- a seal made of a thermoplastic elastomer is preferably arranged, the 'to the upper surface of the titer plate (un ⁇ th in Fig. 1 lying) towards seals the receptacle 14.
- the seal preferably funnel-shaped openings are arranged, which form an inlet port, an outlet and possibly storage positions.
- the biochips 14 may each be held in a plastic ring, which is fixed in the receptacle 14 ', eg glued or welded.
- a plurality of - in this case four - wells 12 each having a biochip 14 are combined to form a unit 21, which is surrounded in FIG. 1 by a dot-dash line.
- At least along this line 21 extends a wall 16 which encloses four recesses 12 and a biochip 14 and protects against contamination.
- the injection-molded part has a thickness d - ie a wall height - of about 50mm to about 60mm.
- the titer plate 10 has 16 such units 21.
- FIG. 2 shows an exemplary embodiment of a reading device 26 for a titer plate 10.
- a number of troughs 13 are arranged, which serve as heatable receptacles for the depressions 12 of the titer plate.
- the bulges 12 'shown in FIG. 1 fit into the tubs 13.
- the four tubs 13 of a unit 21 are each combined to form a thermoblock 11 and can preferably be heated independently of one another and in particular by the other thermoblocks 11.
- the illustrated reading device 26 thus comprises 12 independent 4 thermoblocks 11. With a thermoblock 11, an analyte in the wells 12 can be amplified by means of an amplification reaction to a good amount to be detected.
- the reading device 26 further provides some electrical readout or contact surfaces 15 for the biochips 14.
- a biochip 14 rests on a readout surface 15, so that the corresponding contacts on the biochip 14 are contacted and read out.
- the temperature of the readout surfaces 15 can be controlled.
- 8 electrical contacts are arranged on a Ausleseflä ⁇ che 15, for example.
- the contact surfaces 15 and trays 13 are surrounded by a border 17 which can align and hold a titer plate 10 shown in FIG. 1 on the reading device 26.
- the base area and height of the reading device 26 is preferably compatible with the known STARlet® system, ie the dimensions are, for example, 150 ⁇ 110 ⁇ 110 mm 3 and fit into a 7- track carrier.
- the reading device 26 preferably comprises 12 independent thermo blocks or thermal cycler 11, with which an arbitrarily programmable PCR can be performed, and 12 independent temperature-controlled electrical Bio ⁇ chip read-out blocks.
- the integrated electronics have preferably ⁇ , a communication interface, turkontrollmaschineen 24 independent temperature and 12 independent digital interfaces for the biochip reading on.
- titer plate 10 of FIG. 1 is shown from the top, as it is placed on a reading device 26 of FIG. In this case, the titer plate 10 is supported by the border 17.
- recesses 18 can be seen, each having the shape of an approximately E-shaped elongated hole.
- the recesses 18 penetrate as far as the bottom of the titer plate 10, ie they are "milled in” as a block, and each recess 18 is therefore bounded by relatively thick walls 16 which extend to the recesses 12 in the titer plate 10.
- the walls 16 provide a fenestration of the individual units of wells 12 and the biochip 14. These are located at the bottom 19 of the recess 18 and can be reached by a pipetting robot The pipetting robot moves a pipette tip 40 to transfer an amplified sample mixture from the well 12 in the biochip 14 along the slot 18.
- FIG. 4 schematically shows a plan view of a single unit 21 comprising a biochip and four depressions of a titer plate 10 from the upper side 20.
- a recess 18 is introduced in the titer plate 10.
- the recess 18 is formed as a slot and enclosed by the walls 16.
- To the top 20 towards the recess 18 is open.
- Through the recess 18 can be seen on the bottom 19 of the titer plate 10, in which four depressions 12 shown on the right are embedded.
- On the left side of the biochip 14 is below the dashed line.
- the biochip 14 is covered, for example, by a seal 30, in which a filling port is inserted at 32, by means of which a sample can be brought into contact with the biochip 14 by means of a pipette tip.
- the seal 30 on the biochip 14 is not permeable, but provided with a small receptacle for a pipette tip.
- This receptacle may be, for example, a small depression in the seal 30 in which a pipette tip can be received. However, such depressions are not absolutely necessary.
- a pipette tip can be deposited at positions 33 and 35. Therefore, these positions 33, 35 are connected to the slot 18.
- the opening of the pipette tip is sealed by the elastomeric material of the seal 30, so that the pipette tip can still be filled with eg substrate or label enzyme when it is parked at one of these storage positions 33 or 35.
- an opening of an overflow reservoir is arranged. This position is not connected to the slot 18, since it is not necessary to move to this position a pipette tip.
- Recess 18 designed in the form of a multi-membered elongated hole, which makes, inter alia, the four wells "accessible from above.” That means that pipette tips 40 can be introduced and moved by means of a pipetting robot via the slot 18. The inserted pipette tip reached be made without departing from the recess 18 to Müs ⁇ sen both all the wells 12 and the biochip 14. a target containing the amplified sample can be taken up by the pipette from one of the pits 12 transferred via the injection port 32 in the biochip fourteenth the
- Fill port 32 penetrates the elastomeric seal or coating 30 that is applied to the biochip 14 for protection. Via the filling port 32, the liquid sample passes from a pipette tip 40 into a biochip chamber 36, which is arranged adjacent to the sensitive surfaces of the biochip 14 and in particular runs between the biochip 14 and the seal 30. From the biochip chamber 36 goes from an overflow reservoir 24, which is open to the top. In the overflow reservoir 24, a wick element 31 is arranged, in this case a zy ⁇ linderförmiges piece of absorbent material, such as foam or cotton wool. From the biochip chamber 34, the liquid sample from a pipette tip 40 thus continues to run into the overflow reservoir 24.
- a pipette tip may remain in 6 different positions within the recess 18 after use: if the pipette spit is still filled, e.g. With label or substrate, in particular with a liquid that will be needed again later, it can be parked on one of the two storage positions 33, 35, where its opening is closed by the seal 30.
- An empty, used pipette tip e.g. after pipetting PCR product from one of the depressions 12 via the filling port 32 into the biochip chamber 36, it is possible to deposit in the respective depression 12. After the transfer of PCR product into the biochip chamber 36, the pipette tip can be completely emptied, since the biochip chamber 36 is connected directly to the overflow reservoir 24, into which all excess liquid is sucked off.
- FIG. 5 shows a combination of a titer plate 10 with a reading device 26 in longitudinal section, again showing only one unit 21.
- the titer plate 10 comprises a plurality of depressions 12, the bulges 12 'of which are introduced into troughs 13 of a thermoblock 11.
- the introduced sample material is copied several times by means of a thermocyclization reaction, such as a PCR.
- a barrier medium 28 - here a mineral oil film - is provided in one of the wells 12.
- To the wells 12 close to walls 16, which are open to the first side 20.
- pipette tips 40 introduced by a pipetting robot can reach the recesses 12.
- the wall 14 is not cut, but recognizable in plan view.
- the biochip 14 is surrounded by a plastic ring 41, which preferably has a sealing lip and seals the biochip 14 against the titer plate 10 or the seal 30.
- the biochip 14 has as a contamination protection a seal 30, e.g. made of polypropylene.
- a biochip chamber 36 is formed, into which a sample can be taken.
- the amplified sample can be transferred with the pipette tip 40 via a filling port 32 into the biochip chamber 36, wherein the bounded recess 18 is not left.
- a bore 38 is arranged between the recesses 12 and the filling port 32.
- This bore 38 penetrates the entire titer plate 10.
- a vacuum or vacuum By applying a vacuum or vacuum, a steady stream of air can be generated which further reduces the likelihood of contamination with sample material.
- the air flow enters the titer plate 10 via the first side 20.
- An aerosol, droplets or the like is then removed with the air flow through the bore 38.
- the bore 38 may also be covered with a filter material 39.
- an intermediate wall 37 is provided as an overflow reservoir. provided as shown in Figure 5.
- a Saugdocht which can absorb excess sample liquid and conducts it by means of capillary forces in the overflow reservoir 24, which can accommodate about 1.3ml liquid.
- the overflow reservoir 24 is arranged directly above the outlet 34, but separated from the biochip chamber 36 by a gap.
- the overflow reservoir 24 is almost completely filled with a wicking element, as shown in Fig. 4, which can hold about 1 to 2 ml of liquid. Liquid occurring at the outlet 34 is absorbed by the wick. Due to the gap, the liquid flow breaks off immediately, if no liquid is replenished. In this way, no return flow, not even by capillary forces.
- the method according to the invention for the detection of an analyte by means of a biochip 14 can be performed ⁇ .
- the biochip 14 is integrated in a titer plate 10 in ⁇ as described above.
- the method comprises the following steps: introduction of a sample into one of the depressions 12 of the titer plate 10 and introduction of reagents into the depressions 12
- the inventive method is characterized in that the liquids are transferred by means of a pipetting robot with the pipette tip 40 and the pipette tip 40 remains within the enclosed space 18. For this purpose, it is stored in one of the recesses 12 or on one of the storage positions 33, 35.
- the use of pipetting robots considerably speeds up the analysis process, is less error-prone and more cost-effective.
- FIG. 6 An inventive method for detecting an analyte by means of biochips 14 is shown in FIG. 6 as a flow chart. It first comprises the introduction 102 of one or more sample (s) to be examined into one or more of the wells 12 of a titer plate 10.
- This titer plate 10 is preferably a titer plate 10 according to the invention as described above.
- the pipette tip 40 brought into contact with the sample can then be disposed of in the usual way by a pipetting robot.
- reagents required for an amplification reaction of the analyte are introduced into the recesses 12.
- a further Pi ⁇ pettenspitze introduced by pipetting robot 40 into the recess 18 and preferably thereafter disposed of in the usual way except ⁇ half the recess.
- the sample may be overcoated with mineral oil prior to the amplification reaction.
- Temperature program 106 performed to run off a PCR reaction ⁇ run.
- the reaction mixture then contains the analyte in bulk copied form for better detection.
- the pipetting robot picks up a new, clean Pi ⁇ pettenspitze 40, step 108.
- this pipette tip is transferred in step 110, the reaction mixture having the amplifizier- th sample from a first of the recesses 12 in the biochip fourteenth
- the reaction mixture is introduced into the Biochipkam ⁇ mer 36th Possibly too much captured running ⁇ reaction mixture through the outlet 34 into the overflow reservoir 24.
- the used pipette tip is after the complete unloading emptied at the first recess 12, step 114, ie it remains within the recess 18th
- the pipetting robot initially picks up another new, clean pipette tip 40, step 116.
- this pipette tip is made in step 118 a label enzyme from a befindlichem outside the recess 18 reservoir on ⁇ and transferred to the biochip fourteenth
- the pipette tip 40 is then not yet empty, and is therefore stored at the first storage position 33, step 120, that is, it remains ⁇ ver within the recess 18th
- the liquid-handling robot picks up a further new clean pipette tip 40, step 122.
- this pipette tip is received in step 124, a substrate made of a befindlichem outside the recess 18 from ⁇ reservoir and transferred into the biochip fourteenth
- the pipette tip 40 is then not empty and is therefore deposited at the second storage position 35, step 126, ie it remains within the recess 18th
- biochip 14 may be read out, step 128.
- Steps 110 to 128 may be repeated several more times with the other reaction mixtures from the other wells 12.
- the pipette tip used to pipette the reaction mixture from the well 12 is returned to the respective well 12 and remains there until it is disposed of together with the titer plate 10.
- Substrate were transferred are used again and there ⁇ parked again at the storage positions 33, 35.
- the invention thus allows, used pipette tips do not have other recesses 18 in which are ⁇ tersucht other samples un having to dispose of time and thus reduces the risk of contamination.
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008025992A DE102008025992B4 (en) | 2008-05-30 | 2008-05-30 | Titer plate and method for detecting an analyte |
PCT/EP2009/056231 WO2009144173A2 (en) | 2008-05-30 | 2009-05-22 | Titer plate, reading device therefor and method for detecting an analyte, and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2280778A2 true EP2280778A2 (en) | 2011-02-09 |
EP2280778B1 EP2280778B1 (en) | 2018-07-25 |
Family
ID=40958038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09753828.4A Active EP2280778B1 (en) | 2008-05-30 | 2009-05-22 | Titer plate and method for detecting an analyte |
Country Status (6)
Country | Link |
---|---|
US (1) | US8383393B2 (en) |
EP (1) | EP2280778B1 (en) |
JP (1) | JP5675592B2 (en) |
CN (1) | CN102046290B (en) |
DE (1) | DE102008025992B4 (en) |
WO (1) | WO2009144173A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009057223B4 (en) * | 2009-12-05 | 2016-03-24 | Chemagen Biopolymer-Technologie Aktiengesellschaft | Sample vessel matrix and its production process |
JP5623888B2 (en) * | 2009-12-10 | 2014-11-12 | エフ.ホフマン−ラ ロシュアーゲーF.Hoffmann−La Roche Aktiengesellschaft | Method for separating and detecting analytes |
US11560585B2 (en) | 2011-01-31 | 2023-01-24 | Roche Sequencing Solutions, Inc. | Methods of identifying multiple epitopes in cells |
EP2670863B1 (en) | 2011-01-31 | 2018-06-27 | H. Hoffnabb-La Roche Ag | Methods of identifying multiple epitopes in cells |
DE102012100824A1 (en) * | 2012-02-01 | 2013-09-05 | Albert-Ludwigs-Universität Freiburg | Multiplexed Digital PCR |
CN104307584B (en) * | 2014-09-25 | 2015-09-16 | 瑞安市富日包装机械有限公司 | Dropper unit mahine |
JP2019513235A (en) * | 2016-03-15 | 2019-05-23 | アボット モレキュラー インク. | System and method for automated analysis |
US10591502B2 (en) | 2017-04-03 | 2020-03-17 | Hewlett-Packard Development Company, L.P. | Cassettes including overflow reservoirs |
US11524290B2 (en) | 2017-09-21 | 2022-12-13 | University Of Cincinnati | Discrete volume dispensing system flow rate and analyte sensor |
CA3105025C (en) * | 2018-06-29 | 2021-11-02 | Siemens Healthcare Diagnostics Inc. | Stacked sensor assembly for fluid analyzer |
CN211420183U (en) * | 2019-11-13 | 2020-09-04 | 中国人民解放军军事科学院军事医学研究院 | Nucleic acid amplification reaction tube |
DE102020128003A1 (en) * | 2020-10-23 | 2020-12-31 | Bmg Labtech Gmbh | Microplate reader |
CN113083388B (en) * | 2021-04-26 | 2022-10-25 | 苏州德运康瑞生物科技有限公司 | Automatic interfacing apparatus of chip of dyeing appearance is caught to blood cell |
KR102579228B1 (en) * | 2021-05-28 | 2023-09-19 | (주)에프피에이 | Automatic System for Urine Analysis |
KR102594644B1 (en) * | 2021-05-28 | 2023-10-30 | (주)에프피에이 | Automatic System for Urine Analysis |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1292176C (en) | 1985-09-18 | 1991-11-19 | Joel M. Blatt | Volume metering capillary gap device for applying a liquid sample onto a reactive surface |
JPH07119769B2 (en) * | 1986-10-01 | 1995-12-20 | 株式会社日立製作所 | Automatic analyzer |
US5244630A (en) * | 1988-04-22 | 1993-09-14 | Abbott Laboratories | Device for performing solid-phase diagnostic assay |
DE19646505A1 (en) * | 1996-11-12 | 1998-05-14 | Itt Ind Gmbh Deutsche | Device for carrying out tests on cell samples and the like |
JP2001512691A (en) | 1997-08-12 | 2001-08-28 | ユニバーシティ・オブ・サザン・カリフォルニア | An electrochemical reporter system for examining immunoassay analysis and molecular biological processes |
US6780617B2 (en) * | 2000-12-29 | 2004-08-24 | Chen & Chen, Llc | Sample processing device and method |
DE19916867A1 (en) * | 1999-04-14 | 2000-10-19 | Fraunhofer Ges Forschung | Making a molecular array on which molecules are immobilized, using micro-compartments or microcapillary reactors on planar substrates with sensor elements employs microelectronic production techniques |
US6225109B1 (en) * | 1999-05-27 | 2001-05-01 | Orchid Biosciences, Inc. | Genetic analysis device |
US7070740B1 (en) * | 2000-09-28 | 2006-07-04 | Beckman Coulter, Inc. | Method and apparatus for processing biomolecule arrays |
US6699665B1 (en) * | 2000-11-08 | 2004-03-02 | Surface Logix, Inc. | Multiple array system for integrating bioarrays |
DE10058397A1 (en) | 2000-11-24 | 2002-06-06 | Siemens Ag | Arrangement for an electrochemical analysis method and its use |
EP1388587A4 (en) * | 2001-05-11 | 2006-12-06 | Matsushita Electric Ind Co Ltd | Biomolecular substrate and method and apparatus for examination and diagnosis using the same |
DE10126341A1 (en) | 2001-05-30 | 2002-12-12 | Siemens Ag | Electrochemical DNA sensor, method for producing and operating such a DNA sensor |
US7201833B2 (en) * | 2001-06-04 | 2007-04-10 | Epocal Inc. | Integrated solid-phase hydrophilic matrix circuits and micro-arrays |
US20030049866A1 (en) * | 2001-09-05 | 2003-03-13 | Genicon Sciences Corporation | Sample device preservation |
US7854896B2 (en) * | 2001-09-25 | 2010-12-21 | Becton, Dickinson And Company | Closed system storage plates |
JP3892743B2 (en) * | 2002-03-01 | 2007-03-14 | 日本碍子株式会社 | Reaction cell and method of use thereof |
WO2003087410A1 (en) | 2002-04-11 | 2003-10-23 | Sequenom, Inc. | Methods and devices for performing chemical reactions on a solid support |
EP1502108A4 (en) * | 2002-04-24 | 2007-03-21 | Surface Logix Inc | Device and method for monitoring leukocyte migration |
DE10233212B4 (en) * | 2002-07-22 | 2006-07-06 | Siemens Ag | Measuring device with a biochip arrangement and use of the device for a high-throughput analysis method |
WO2004092322A2 (en) * | 2003-04-14 | 2004-10-28 | Surface Logix, Inc. | Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells |
JP2005077308A (en) * | 2003-09-02 | 2005-03-24 | Corona Giken Kogyo Kk | Specimen tray and using method of specimen tray |
DE102005051850A1 (en) * | 2005-10-28 | 2007-05-03 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for duplication and detection of nucleic acids |
DE102005059535B4 (en) | 2005-12-13 | 2010-01-14 | Siemens Ag | Device and method for carrying out a nucleic acid test, and method for producing such a device |
DK1963853T3 (en) * | 2005-12-21 | 2016-06-13 | Meso Scale Technologies Llc | Assaymoduler with the assay reagents and methods of making and using the same |
US8562920B2 (en) | 2006-03-28 | 2013-10-22 | Universal Bio Research Co., Ltd. | Micro plate treating device and micro plate treating method |
EP2091647A2 (en) * | 2006-11-14 | 2009-08-26 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
-
2008
- 2008-05-30 DE DE102008025992A patent/DE102008025992B4/en active Active
-
2009
- 2009-05-22 US US12/994,906 patent/US8383393B2/en active Active
- 2009-05-22 WO PCT/EP2009/056231 patent/WO2009144173A2/en active Application Filing
- 2009-05-22 JP JP2011510959A patent/JP5675592B2/en not_active Expired - Fee Related
- 2009-05-22 EP EP09753828.4A patent/EP2280778B1/en active Active
- 2009-05-22 CN CN200980120047.9A patent/CN102046290B/en active Active
Non-Patent Citations (1)
Title |
---|
See references of WO2009144173A2 * |
Also Published As
Publication number | Publication date |
---|---|
JP5675592B2 (en) | 2015-02-25 |
US20110076690A1 (en) | 2011-03-31 |
EP2280778B1 (en) | 2018-07-25 |
DE102008025992B4 (en) | 2011-01-27 |
JP2011524004A (en) | 2011-08-25 |
CN102046290A (en) | 2011-05-04 |
WO2009144173A3 (en) | 2010-01-21 |
WO2009144173A2 (en) | 2009-12-03 |
US8383393B2 (en) | 2013-02-26 |
CN102046290B (en) | 2014-08-06 |
DE102008025992A1 (en) | 2009-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2280778B1 (en) | Titer plate and method for detecting an analyte | |
DE60016415T2 (en) | GENETIC EXPERIMENTAL SYSTEM | |
WO2018086901A1 (en) | Device and method for the inclined processing of microfluidic cartridges | |
EP0938383B1 (en) | Device for carrying out research on cell specimens and similar material | |
DE69719782T2 (en) | DEVICE AND METHOD FOR CARRYING OUT ASSAYS | |
DE69532953T2 (en) | MOLECULAR ANALYZER AND METHOD FOR ITS USE | |
EP1110609B1 (en) | System for sample processing in a multi-chamber device | |
DE10218988C1 (en) | Device and method for wetting objects | |
EP2654955B1 (en) | Method for mixing at least one sample solution with reagents | |
DE102010053913A1 (en) | Method for separating and detecting an analyte | |
EP0676643A2 (en) | System for contamination-free reaction processes | |
EP1160573A2 (en) | Microtitre plate and coupled multiple pipettor | |
DE102006057300A1 (en) | Arrangement for processing a plurality of samples for analysis | |
WO2015106932A1 (en) | Method for operating a microfluidic chip and microfluidic chip | |
DE102018111822B4 (en) | Fluidic system for receiving, dispensing and moving liquids, method for processing fluids in a fluidic system | |
DE602004009775T2 (en) | Device for reliable analysis | |
EP2482982A1 (en) | Flat body in the manner of a chip card for biochemical analysis and method for the use thereof | |
EP1304166A1 (en) | Flow through reaction chamber with sensor chip | |
EP2269028B1 (en) | Dispensing head | |
EP2169383A1 (en) | Body for flow through cuvettes and use thereof | |
DE102005049976A1 (en) | Cartridge card for automated DNA or protein analysis has a geometric array of micro-channels with dry reagents | |
DE10118905A1 (en) | Apparatus useful for cell culture comprises wells of microtiter plate with cover which has chamber with inlet and outlet and which is filled with culture medium, all or part of which is replaced during culture | |
EP0907414A1 (en) | Method for achieving chemical, in particular biochemical reactions and pipette tip with reaction vessel and with optional additional receiving component for said pipette tip | |
EP1510254A2 (en) | Method and device for detecting an analyte in a fluid | |
DE102004006428B4 (en) | Device for carrying out investigations on biocomponents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20101026 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SIEMENS AKTIENGESELLSCHAFT |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BOEHRINGER INGELHEIM VETMEDICA GMBH |
|
17Q | First examination report despatched |
Effective date: 20160623 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20180410 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1021177 Country of ref document: AT Kind code of ref document: T Effective date: 20180815 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502009015126 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20180725 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181025 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181026 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181025 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181125 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502009015126 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20190426 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190531 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190531 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20190531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190522 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190522 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181125 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 1021177 Country of ref document: AT Kind code of ref document: T Effective date: 20190522 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190522 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20090522 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180725 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20220520 Year of fee payment: 14 Ref country code: FR Payment date: 20220523 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20220620 Year of fee payment: 15 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20230522 |